Acceleron Pharma
XLRN
#1812
Rank
โ‚ฌ9.38 B
Marketcap
153,53ย โ‚ฌ
Share price
0.00%
Change (1 day)
13,672.79%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: โ‚ฌ9.38 Billion

As of December 2025 Acceleron Pharma has a market cap of โ‚ฌ9.38 Billion. This makes Acceleron Pharma the world's 1812th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022โ‚ฌ10.19 B5.58%
2021โ‚ฌ9.65 B54.02%
2020โ‚ฌ6.26 B149.26%
2019โ‚ฌ2.51 B42.77%
2018โ‚ฌ1.76 B10.07%
2017โ‚ฌ1.60 B74.71%
2016โ‚ฌ0.91 B-38.35%
2015โ‚ฌ1.48 B42.99%
2014โ‚ฌ1.03 B27.81%
2013โ‚ฌ0.81 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚ฌ152.57 B 1,525.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ65.39 B 596.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ417.86 B 4,350.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚ฌ17.95 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚ฌ0.14 B-98.47%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
โ‚ฌ41.8 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ127.11 B 1,253.86%๐Ÿ‡บ๐Ÿ‡ธ USA